32
Participants
Start Date
January 31, 2008
Primary Completion Date
February 28, 2015
Study Completion Date
November 30, 2016
A-dmDT390-bisFv(UCHT1)
A-dmDT390-bisFv(UCHT1) will be administered as 60 μg/kg total given as 7.5 μg/kg/injection twice a day 4-6 hours apart for four consecutive days (days 1-4) into a free flowing IV over a period of approximately 15 minutes
James Graham Brown Cancer Center, Louisville
Scott and White Hospital & Clinic, Temple
University of Texas MD Anderson Cancer Center, Houston
Yale University School Of Medicine Recruiting, New Haven
University of Texas Southwestern Medical Center, Dallas
Lead Sponsor
James Graham Brown Cancer Center
OTHER
M.D. Anderson Cancer Center
OTHER
Scott and White Hospital & Clinic
OTHER
University of Texas Southwestern Medical Center
OTHER
Yale University
OTHER
Angimmune LLC
INDUSTRY